The Biotech Growth Trust (LON:BIOG) Shares Up 2% - Time to Buy?

Key Points

• Shares of The Biotech Growth Trust PLC (LON:BIOG) rose by 2% to a trading price of GBX 1,025 ($13.82) on Wednesday, despite a 24% decline in trading volume compared to the average.
• The company has a market capitalization of £244.42 million and a P/E ratio of -390.77, highlighting potential investor concerns.
• The Biotech Growth Trust focuses on capital appreciation through investments in the biotechnology industry, with performance benchmarks set against the NASDAQ Biotechnology Index.

Shares of The Biotech Growth Trust PLC (LON:BIOG - ) shot up 2% during trading on Wednesday . The company traded as high as GBX 1,025 ($13.82) and last traded at GBX 1,025 ($13.82). 110,514 shares traded hands during trading, a decline of 24% from the average session volume of 144,778 shares. The stock had previously closed at GBX 1,005 ($13.55).

The Biotech Growth Trust Stock Performance

The company has a fifty day moving average price of GBX 892.27 and a two-hundred day moving average price of GBX 787.17. The company has a debt-to-equity ratio of 11.02, a current ratio of 0.59 and a quick ratio of 0.00. The company has a market capitalization of £244.42 million, a P/E ratio of -390.77 and a beta of 0.50.

About The Biotech Growth Trust

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.